Abstract
Summary
Biomarker testing is a group of tests that looks for these molecular signs of health so that doctors can plan the best care during the clinic treatment.
LPI (LP Information)' newest research report, the “Clinical Biomarker Testing Industry Forecast” looks at past sales and reviews total world Clinical Biomarker Testing sales in 2022, providing a comprehensive analysis by region and market sector of projected Clinical Biomarker Testing sales for 2023 through 2029. With Clinical Biomarker Testing sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Clinical Biomarker Testing industry.
This Insight Report provides a comprehensive analysis of the global Clinical Biomarker Testing landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Clinical Biomarker Testing portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Clinical Biomarker Testing market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Clinical Biomarker Testing and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Clinical Biomarker Testing.
The global Clinical Biomarker Testing market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
Biomarker testing is a group of tests that looks for these molecular signs of health so that doctors can plan the best care during the clinic treatment.
This report presents a comprehensive overview, market shares, and growth opportunities of Clinical Biomarker Testing market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
Cancer
Metabolism
Infectious Disease
Cardiology
Neurology
Immunological Disease
Segmentation by application
Drug Discovery
Nutrigenomics
Toxicology Testing
Personalized Medicine
Functional Genomics
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Abbott Laboratories
AbbVie Inc.
Adaptive Biotechnologies
Agilent Technologies
BD
Becton Dickinson
Bio-Rad Laboratories
Danaher Corporation
Merck and Co.
Thermofisher Scientific
LPI (LP Information)' newest research report, the “Clinical Biomarker Testing Industry Forecast” looks at past sales and reviews total world Clinical Biomarker Testing sales in 2022, providing a comprehensive analysis by region and market sector of projected Clinical Biomarker Testing sales for 2023 through 2029. With Clinical Biomarker Testing sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Clinical Biomarker Testing industry.
This Insight Report provides a comprehensive analysis of the global Clinical Biomarker Testing landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Clinical Biomarker Testing portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Clinical Biomarker Testing market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Clinical Biomarker Testing and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Clinical Biomarker Testing.
The global Clinical Biomarker Testing market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
Biomarker testing is a group of tests that looks for these molecular signs of health so that doctors can plan the best care during the clinic treatment.
This report presents a comprehensive overview, market shares, and growth opportunities of Clinical Biomarker Testing market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
Cancer
Metabolism
Infectious Disease
Cardiology
Neurology
Immunological Disease
Segmentation by application
Drug Discovery
Nutrigenomics
Toxicology Testing
Personalized Medicine
Functional Genomics
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Abbott Laboratories
AbbVie Inc.
Adaptive Biotechnologies
Agilent Technologies
BD
Becton Dickinson
Bio-Rad Laboratories
Danaher Corporation
Merck and Co.
Thermofisher Scientific
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Clinical Biomarker Testing Market Size 2018-2029
2.1.2 Clinical Biomarker Testing Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Clinical Biomarker Testing Segment by Type
2.2.1 Cancer
2.2.2 Metabolism
2.2.3 Infectious Disease
2.2.4 Cardiology
2.2.5 Neurology
2.2.6 Immunological Disease
2.3 Clinical Biomarker Testing Market Size by Type
2.3.1 Clinical Biomarker Testing Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Clinical Biomarker Testing Market Size Market Share by Type (2018-2023)
2.4 Clinical Biomarker Testing Segment by Application
2.4.1 Drug Discovery
2.4.2 Nutrigenomics
2.4.3 Toxicology Testing
2.4.4 Personalized Medicine
2.4.5 Functional Genomics
2.5 Clinical Biomarker Testing Market Size by Application
2.5.1 Clinical Biomarker Testing Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Clinical Biomarker Testing Market Size Market Share by Application (2018-2023)
3 Clinical Biomarker Testing Market Size by Player
3.1 Clinical Biomarker Testing Market Size Market Share by Players
3.1.1 Global Clinical Biomarker Testing Revenue by Players (2018-2023)
3.1.2 Global Clinical Biomarker Testing Revenue Market Share by Players (2018-2023)
3.2 Global Clinical Biomarker Testing Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Clinical Biomarker Testing by Regions
4.1 Clinical Biomarker Testing Market Size by Regions (2018-2023)
4.2 Americas Clinical Biomarker Testing Market Size Growth (2018-2023)
4.3 APAC Clinical Biomarker Testing Market Size Growth (2018-2023)
4.4 Europe Clinical Biomarker Testing Market Size Growth (2018-2023)
4.5 Middle East & Africa Clinical Biomarker Testing Market Size Growth (2018-2023)
5 Americas
5.1 Americas Clinical Biomarker Testing Market Size by Country (2018-2023)
5.2 Americas Clinical Biomarker Testing Market Size by Type (2018-2023)
5.3 Americas Clinical Biomarker Testing Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Clinical Biomarker Testing Market Size by Region (2018-2023)
6.2 APAC Clinical Biomarker Testing Market Size by Type (2018-2023)
6.3 APAC Clinical Biomarker Testing Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Clinical Biomarker Testing by Country (2018-2023)
7.2 Europe Clinical Biomarker Testing Market Size by Type (2018-2023)
7.3 Europe Clinical Biomarker Testing Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Clinical Biomarker Testing by Region (2018-2023)
8.2 Middle East & Africa Clinical Biomarker Testing Market Size by Type (2018-2023)
8.3 Middle East & Africa Clinical Biomarker Testing Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Clinical Biomarker Testing Market Forecast
10.1 Global Clinical Biomarker Testing Forecast by Regions (2024-2029)
10.1.1 Global Clinical Biomarker Testing Forecast by Regions (2024-2029)
10.1.2 Americas Clinical Biomarker Testing Forecast
10.1.3 APAC Clinical Biomarker Testing Forecast
10.1.4 Europe Clinical Biomarker Testing Forecast
10.1.5 Middle East & Africa Clinical Biomarker Testing Forecast
10.2 Americas Clinical Biomarker Testing Forecast by Country (2024-2029)
10.2.1 United States Clinical Biomarker Testing Market Forecast
10.2.2 Canada Clinical Biomarker Testing Market Forecast
10.2.3 Mexico Clinical Biomarker Testing Market Forecast
10.2.4 Brazil Clinical Biomarker Testing Market Forecast
10.3 APAC Clinical Biomarker Testing Forecast by Region (2024-2029)
10.3.1 China Clinical Biomarker Testing Market Forecast
10.3.2 Japan Clinical Biomarker Testing Market Forecast
10.3.3 Korea Clinical Biomarker Testing Market Forecast
10.3.4 Southeast Asia Clinical Biomarker Testing Market Forecast
10.3.5 India Clinical Biomarker Testing Market Forecast
10.3.6 Australia Clinical Biomarker Testing Market Forecast
10.4 Europe Clinical Biomarker Testing Forecast by Country (2024-2029)
10.4.1 Germany Clinical Biomarker Testing Market Forecast
10.4.2 France Clinical Biomarker Testing Market Forecast
10.4.3 UK Clinical Biomarker Testing Market Forecast
10.4.4 Italy Clinical Biomarker Testing Market Forecast
10.4.5 Russia Clinical Biomarker Testing Market Forecast
10.5 Middle East & Africa Clinical Biomarker Testing Forecast by Region (2024-2029)
10.5.1 Egypt Clinical Biomarker Testing Market Forecast
10.5.2 South Africa Clinical Biomarker Testing Market Forecast
10.5.3 Israel Clinical Biomarker Testing Market Forecast
10.5.4 Turkey Clinical Biomarker Testing Market Forecast
10.5.5 GCC Countries Clinical Biomarker Testing Market Forecast
10.6 Global Clinical Biomarker Testing Forecast by Type (2024-2029)
10.7 Global Clinical Biomarker Testing Forecast by Application (2024-2029)
11 Key Players Analysis
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Information
11.1.2 Abbott Laboratories Clinical Biomarker Testing Product Offered
11.1.3 Abbott Laboratories Clinical Biomarker Testing Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 Abbott Laboratories Main Business Overview
11.1.5 Abbott Laboratories Latest Developments
11.2 AbbVie Inc.
11.2.1 AbbVie Inc. Company Information
11.2.2 AbbVie Inc. Clinical Biomarker Testing Product Offered
11.2.3 AbbVie Inc. Clinical Biomarker Testing Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 AbbVie Inc. Main Business Overview
11.2.5 AbbVie Inc. Latest Developments
11.3 Adaptive Biotechnologies
11.3.1 Adaptive Biotechnologies Company Information
11.3.2 Adaptive Biotechnologies Clinical Biomarker Testing Product Offered
11.3.3 Adaptive Biotechnologies Clinical Biomarker Testing Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 Adaptive Biotechnologies Main Business Overview
11.3.5 Adaptive Biotechnologies Latest Developments
11.4 Agilent Technologies
11.4.1 Agilent Technologies Company Information
11.4.2 Agilent Technologies Clinical Biomarker Testing Product Offered
11.4.3 Agilent Technologies Clinical Biomarker Testing Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 Agilent Technologies Main Business Overview
11.4.5 Agilent Technologies Latest Developments
11.5 BD
11.5.1 BD Company Information
11.5.2 BD Clinical Biomarker Testing Product Offered
11.5.3 BD Clinical Biomarker Testing Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 BD Main Business Overview
11.5.5 BD Latest Developments
11.6 Becton Dickinson
11.6.1 Becton Dickinson Company Information
11.6.2 Becton Dickinson Clinical Biomarker Testing Product Offered
11.6.3 Becton Dickinson Clinical Biomarker Testing Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 Becton Dickinson Main Business Overview
11.6.5 Becton Dickinson Latest Developments
11.7 Bio-Rad Laboratories
11.7.1 Bio-Rad Laboratories Company Information
11.7.2 Bio-Rad Laboratories Clinical Biomarker Testing Product Offered
11.7.3 Bio-Rad Laboratories Clinical Biomarker Testing Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 Bio-Rad Laboratories Main Business Overview
11.7.5 Bio-Rad Laboratories Latest Developments
11.8 Danaher Corporation
11.8.1 Danaher Corporation Company Information
11.8.2 Danaher Corporation Clinical Biomarker Testing Product Offered
11.8.3 Danaher Corporation Clinical Biomarker Testing Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 Danaher Corporation Main Business Overview
11.8.5 Danaher Corporation Latest Developments
11.9 Merck and Co.
11.9.1 Merck and Co. Company Information
11.9.2 Merck and Co. Clinical Biomarker Testing Product Offered
11.9.3 Merck and Co. Clinical Biomarker Testing Revenue, Gross Margin and Market Share (2018-2023)
11.9.4 Merck and Co. Main Business Overview
11.9.5 Merck and Co. Latest Developments
11.10 Thermofisher Scientific
11.10.1 Thermofisher Scientific Company Information
11.10.2 Thermofisher Scientific Clinical Biomarker Testing Product Offered
11.10.3 Thermofisher Scientific Clinical Biomarker Testing Revenue, Gross Margin and Market Share (2018-2023)
11.10.4 Thermofisher Scientific Main Business Overview
11.10.5 Thermofisher Scientific Latest Developments
12 Research Findings and Conclusion